Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents

Author： Woodland Cindy Koren Gideon Wainer Irving W Batist Gerry Ito Shinya

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.81, Iss.8, 2003-08, pp. : 800-805

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance

By Baranck M. Bohacova V. Kvackajova J. Hudecova S. Krizanova O. Breier A.

European Journal of Pharmaceutical Sciences, Vol. 14, Iss. 1, 2001-08 ,pp. : 29-36

Elsevier

Access to resources Recommend Favorite

Multidrug Resistance Phenotype Mediated by the P-Glycoprotein-Like Transporter in Leishmania: A Search for Reversal Agents

Current Drug Targets, Vol. 3, Iss. 4, 2002-08 ,pp. : 311-333

Bentham Science Publishers

Access to resources Recommend Favorite

Combating P-glycoprotein-Mediated Multidrug Resistance Using Therapeutic Nanoparticles

Current Pharmaceutical Design, Vol. 19, Iss. 37, 2013-11 ,pp. : 6655-6666

Bentham Science Publishers

Access to resources Recommend Favorite

Dihidro-&bgr;-Agarofuran Sesquiterpenes: A New Class of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in the Protozoan Parasite Leishmania

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-09 ,pp. : 3125-3139

Bentham Science Publishers

Access to resources Recommend Favorite

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 813-821

Bentham Science Publishers

Access to resources Recommend Favorite